Had another good read and even if the success percentages aren't as good as the HerVaxx results it is still great for a world first B-cell vaxx.
Lesley again and again in her interviews mentioned the importance of trial data, now we got them from 2 vaxx. They will use all their knowledge to make KeyVaxx an even more efficient vaxx.
It took the big players in the US about 5 years to jump on T-cell, how long will it take to realise that B-cell is more efficient, cheaper, long lasting and saver.
Time will tell,
GLTA
Hard to believe?, page-136
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
